Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 0.0 | 0.3 | 0.0 | 0.0 | 0.0 | 0.4 | 0.1 | 0.0 |
| Revenue growth | -100.0% | | | | -100.0% | 640.7% | | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.3 | 0.0 | 0.0 | 0.0 | 0.4 | 0.1 | 0.0 |
| Gross margin | | 100.0% | | | | 100.0% | 100.0% | |
| Selling, general and administrative | 41.5 | 49.6 | | | | | | 9.5 |
| Research and development | 29.0 | 35.0 | 38.8 | 37.2 | 18.5 | 8.2 | 4.3 | 19.4 |
| General and administrative | | | 13.1 | 10.7 | 11.1 | 2.8 | 1.7 | |
| EBIT | 0.0 | -43.9 | -52.2 | -48.4 | -30.0 | -10.9 | -5.9 | -29.3 |
| EBIT margin | | -17094.6% | | | | -2737.0% | -10968.5% | |
| Pre-tax income | -43.0 | -49.6 | -78.2 | -68.6 | -33.4 | -11.3 | -9.0 | -28.7 |
| Income taxes | 0.0 | 0.0 | 0.0 | -7.1 | -3.6 | -0.4 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 10.3% | 10.9% | 3.2% | 0.0% | 0.0% |
| Net income | -43.0 | -49.6 | -78.2 | -61.5 | -30.8 | -11.0 | -9.2 | -28.7 |
| Net margin | | -19305.4% | | | | -2754.3% | -17003.7% | |
| |
| Diluted EPS | ($0.32) | ($0.84) | ($1.95) | ($1.85) | ($1.76) | ($5.62) | ($9.48) | ($0.23) |
| Shares outstanding (diluted) | 133.9 | 59.3 | 40.0 | 33.3 | 17.5 | 2.0 | 1.0 | 122.4 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|